{"id":20335,"date":"2025-10-26T09:00:10","date_gmt":"2025-10-26T00:00:10","guid":{"rendered":"https:\/\/blog.agentsoft.co.kr\/index.php\/2025\/10\/26\/20335\/"},"modified":"2025-10-26T09:00:10","modified_gmt":"2025-10-26T00:00:10","slug":"a-%ec%84%b1%ec%9d%b8%ea%b0%84%ed%98%b8%ed%95%99-%ec%bc%80%ec%9d%b4%ec%8a%a4-%ec%b2%9c%ec%8b%9d-1-%ea%b8%b0%ea%b4%80%ec%a7%80-%eb%b6%84%eb%b9%84%eb%ac%bc%ea%b3%bc-%ea%b4%80%eb%a0%a8%eb%90%9c","status":"publish","type":"post","link":"https:\/\/blog.agentsoft.co.kr\/index.php\/2025\/10\/26\/20335\/","title":{"rendered":"A+ \uc131\uc778\uac04\ud638\ud559 \ucf00\uc774\uc2a4 \ucc9c\uc2dd- 1.\uae30\uad00\uc9c0 \ubd84\ube44\ubb3c\uacfc \uad00\ub828\ub41c \ube44\ud6a8\uacfc\uc801 \ud638\ud761\uc591\uc0c1 \/ 2. \uacfc\ub3c4\ud55c \uae30\uce68\uacfc \uad00\ub828\ub41c \uae09\uc131\ud1b5\uc99d"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/image4.happycampus.com\/Production\/thumb212\/2024\/03\/03\/data29510195-0001.jpg\"><img decoding=\"async\" src=\"https:\/\/image4.happycampus.com\/Production\/thumb212\/2024\/03\/03\/data29510195-0002.jpg\"><\/p>\n<p><strong>\ubaa9\ucc28<\/strong><\/p>\n<p>1. Diagnostic test(s)\/ procedures and laboratory values<br \/>\n2. Therapeutic intervention(s)\/ procedure<br \/>\n3. Medication(s)<br \/>\n4. \uac04\ud638\uacfc\uc815 \uae30\ub85d\uc9c0<br \/>\n5. \ucc38\uace0\ubb38\ud5cc<\/p>\n<p><strong>\ubcf8\ubb38\ub0b4\uc6a9<\/strong><\/p>\n<p>\uac04\ud638\uacfc\uc815 \uae30\ub85d\uc9c0 (\uc6b0\uc120\uc21c\uc704 \uc120\uc815 1)<br \/>\n\uc8fc \ud638\uc18c (chief complaints):<br \/>\n\uc8fc\uad00\uc801 \uc790\ub8cc<br \/>\n&#8211; \u201c\ubaa9\uc5d0\uc11c \uac00\ub798\uac00 \uc548 \ub5a8\uc5b4\uc838\uc694.\u201d<br \/>\n&#8211; \u201c\uac00\ub798\uac00 \ub098\uc62c\ub824\uace0 \ud558\uba74 \uc228\uc774 \ub9c9\ud600\uc11c \uc228\uc26c\uae30 \ud798\ub4e4\uc5b4\uc694.\u201d<br \/>\n&#8211; \u201c\uac00\ub798\uac00 \ubaa9\uc744 \ub9c9\uc544\uc11c \uc7a0\uc744 \uc798 \uc218 \uc5c6\uc5b4\uc694.\u201d<br \/>\n&#8211; \u201c\ub204\uc6cc\uc788\uc73c\uba74 \ub354 \uc2ec\ud574\uc838\uc694.\u201d<br \/>\n&#8211; \u201c\uc0b0\uc18c 3L\ub85c \uc62c\ub9ac\uba74 \uc548\ub418\uc694? \uc548 \uc62c\ub824\uc8fc\uba74 \uadf8\ub0e5 \uc548 \ud560 \uac81\ub2c8\ub2e4. \ud574\ubd24\uc790 \ucf54\ub9cc \ub9c8\ub974\uace0 \ucf54\ub531\uc9c0\uac00<br \/>\n\uc0dd\uaca8\uc11c \ubd88\ud3b8\ud569\ub2c8\ub2e4. \ud6a8\uacfc\ub3c4 \uc5c6\ub294\ub370 \uc548 \ud560 \uac81\ub2c8\ub2e4.\u201d<br \/>\n&#8211; \u201c\ud761\uc785\uae30 \ud558\uba74 \ubb50\ud569\ub2c8\uae4c? \ud6a8\uacfc\ub3c4 \uc5c6\ub294\ub370. \uc548\ud558\uace0 \uc774\ub300\ub85c \uc0b4 \uac81\ub2c8\ub2e4.\u201d<br \/>\n&#8211; \u201c\uc870\uae08\ub9cc \uc6c0\uc9c1\uc5ec\ub3c4 \uc228\uc774 \ucc28\uc694.\u201d<br \/>\n-\ubcf4\ud638\uc790 (\ub538) \u201c\uac00\ub798 \ub053\ub294 \uc18c\ub9ac\uac00 \ub4e4\ub824\uc694.\u201d<br \/>\n-\ubcf4\ud638\uc790 (\ub538) \u201c\uc544\ubc84\uc9c0\uac00 \uc228\uc26c\uae30 \ubd88\ud3b8\ud558\uc2dc\ub300\uc694.\u201d<\/p>\n<p>\uac1d\uad00\uc801 \uc790\ub8cc<br \/>\n-\uc9c4\ub2e8\uba85 : Asthma, COPD<br \/>\n&#8211; C\/C : Dyspnea<br \/>\n&#8211; DOE (\uc6b4\ub3d9\uc2dc \ud638\ud761\uace4\ub780) \uc788\uc74c<br \/>\n&#8211; 12\/8 ABGA \uacb0\uacfc<br \/>\nPCO2 27.8, PO2 97.9, Hco3 17.9, O2 Saturation 98.2<br \/>\n&#8211; 11\/28 CT \uacb0\uacfc : asthma, pneumonia<br \/>\n&#8211; 12\/6 Chest PA \uacb0\uacfc :<br \/>\nconsolidation haziness in Rt lung (\uc624\ub978\ucabd \ud3d0\uc758 \uacbd\ud654 \ud63c\ud0c1),<br \/>\nboth pleural effusion of thickening, (\uc591\ucabd \ub18d\ud654\ub41c \ud749\ub9c9\uc0bc\ucd9c)<br \/>\nEmphysema in both lungs, (\uc591\ucabd \ud3d0\uc758 \ud3d0\uae30\uc885)<br \/>\nPneumonia on RLLF, (\uc6b0\uce21\ud558\uc5fd \ud3d0\ub834)<br \/>\nDiffuse interstitial lung disease in both fields, (\uc591\ucabd \ud3d0 \ud655\uc0b0\uc131 \uac04\uc9c8\uc131 \ud3d0\uc9c8\ud658)<br \/>\nDiffuse emphysema, both inactive pulmonary tbc in BULS (\ud655\uc0b0\uc131 \ud398\uae30\uc885, BULS\uc5d0\uc11c \ub458 \ub2e4 \ube44\ud65c\uc131 \ud3d0\uacb0\ud575)<br \/>\n-V\/S : 130\/70-36.6-110-24-99%<br \/>\n&#8211; nasal cannula O2 2L \uc0ac\uc6a9\uc911\uc784<br \/>\n&#8211; Home O2 [EverFlo] \uc0ac\uc6a9\uc911\uc784 (2015~)<br \/>\n&#8211; Nebulizer \uc0ac\uc6a9\uc911\uc784<br \/>\n&#8211; ERDOS CAP, DAXAS TAB \ubcf5\uc6a9\uc911\uc784<br \/>\n&#8211; \uae30\uad00\uc9c0 \ud655\uc7a5\uc81c\uc640 \uc2a4\ud14c\ub85c\uc774\ub4dc \ud761\uc785\uc81c \uc0ac\uc6a9\uc5d0 \ube44\ud611\uc870\uc801\uc778 \ubaa8\uc2b5 \uad00\ucc30\ub428<br \/>\n&#8211; nasal cannula \uc0ac\uc6a9\uc5d0 \ube44\ud611\uc870\uc801\uc778 \ubaa8\uc2b5 \uad00\ucc30\ub428<br \/>\n&#8211; \ud638\ud761 \uc2dc \uadf8\ub989\uac70\ub9ac\uace0 \uc315\uc315\uac70\ub9ac\ub294 \ubaa8\uc2b5 \uad00\ucc30\ub428<br \/>\n&#8211; \ud638\ud761 \uc2dc \ud638\ud761\ubcf4\uc870\uadfc \uc0ac\uc6a9\ud558\ub294 \ubaa8\uc2b5 \uad00\ucc30\ub428<br \/>\n&#8211; \uccad\uc9c4\uc2dc \uc218\ud3ec\uc74c, \ucc9c\uba85\uc74c\uc774 \ub4e4\ub9bc<br \/>\n&#8211; \ud558\ub8e8 20\ud68c \uc774\uc0c1 500\uc6d0\uc9dc\ub9ac \ud06c\uae30\ub85c \uac00\ub798\ub97c \ubc49\uc74c<br \/>\n(\uc591 : \uc57d 10cc \\ \uc0c9\uae54 : \uc810\ub3c4 \ub192\uc740 \ud770 \uc0c9)<\/p>\n<p>\ucd9c\ucc98 : <a href=\"https:\/\/www.happycampus.com\/report-doc\/29510195\/\" target=\"_blank\">\ud574\ud53c\ucea0\ud37c\uc2a4<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\ubaa9\ucc28 1. Diagnostic test(s)\/ procedures and laboratory values 2. Therapeutic intervention(s)\/ procedure 3. Medication(s) 4. \uac04\ud638\uacfc\uc815 \uae30\ub85d\uc9c0 5. \ucc38\uace0\ubb38\ud5cc \ubcf8\ubb38\ub0b4\uc6a9 \uac04\ud638\uacfc\uc815 \uae30\ub85d\uc9c0 (\uc6b0\uc120\uc21c\uc704 \uc120\uc815 1) \uc8fc \ud638\uc18c (chief complaints): \uc8fc\uad00\uc801 \uc790\ub8cc &#8211; \u201c\ubaa9\uc5d0\uc11c \uac00\ub798\uac00 \uc548 \ub5a8\uc5b4\uc838\uc694.\u201d &#8211; \u201c\uac00\ub798\uac00 \ub098\uc62c\ub824\uace0 \ud558\uba74 \uc228\uc774 \ub9c9\ud600\uc11c \uc228\uc26c\uae30 \ud798\ub4e4\uc5b4\uc694.\u201d &#8211; \u201c\uac00\ub798\uac00 \ubaa9\uc744 \ub9c9\uc544\uc11c \uc7a0\uc744 \uc798 \uc218 \uc5c6\uc5b4\uc694.\u201d &#8211; \u201c\ub204\uc6cc\uc788\uc73c\uba74 \ub354 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[22681,22962,25138],"class_list":["post-20335","post","type-post","status-publish","format-standard","hentry","category-uncategorized","tag-22681","tag-22962","tag-25138"],"_links":{"self":[{"href":"https:\/\/blog.agentsoft.co.kr\/index.php\/wp-json\/wp\/v2\/posts\/20335","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.agentsoft.co.kr\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.agentsoft.co.kr\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.agentsoft.co.kr\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.agentsoft.co.kr\/index.php\/wp-json\/wp\/v2\/comments?post=20335"}],"version-history":[{"count":0,"href":"https:\/\/blog.agentsoft.co.kr\/index.php\/wp-json\/wp\/v2\/posts\/20335\/revisions"}],"wp:attachment":[{"href":"https:\/\/blog.agentsoft.co.kr\/index.php\/wp-json\/wp\/v2\/media?parent=20335"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.agentsoft.co.kr\/index.php\/wp-json\/wp\/v2\/categories?post=20335"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.agentsoft.co.kr\/index.php\/wp-json\/wp\/v2\/tags?post=20335"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}